{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:11:41Z","timestamp":1789582301139,"version":"build-2803163510"},"reference-count":44,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.3892\/br.2017.985","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T06:40:06Z","timestamp":1505889606000},"page":"460-468","source":"Crossref","is-referenced-by-count":20,"title":["Serum pepsinogen and gastrin-17 as potential biomarkers for pre-malignant lesions in the gastric corpus"],"prefix":"10.3892","volume":"7","author":[{"given":"Tan Han","family":"Loong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngiu Chai","family":"Soon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nik Ritza Kosai","family":"Nik Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeevinesh","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafiz Abdul","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazefah","family":"Abdul Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjanu Hikmah","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isa","family":"Mohamed Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azmi","family":"Tamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norfilza M.","family":"Mokhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja Affendi","family":"Raja Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,9,20]]},"reference":[{"key":"key20180107142126_b1-br-0-0-985","volume-title":"Ministry of Health Malaysia","author":"Zainal","year":"2007"},{"key":"key20180107142126_b2-br-0-0-985","first-page":"6735","article-title":"Human gastric carcinogenesis: A multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention","volume":"52","author":"Correa","year":"1992","journal-title":"Cancer Res"},{"key":"key20180107142126_b3-br-0-0-985","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1523-5378.2001.00042.x","article-title":"Atrophic gastritis and intestinal metaplasia in Japan: Results of a large multicenter study","volume":"6","author":"Asaka","year":"2001","journal-title":"Helicobacter"},{"key":"key20180107142126_b4-br-0-0-985","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1158\/1055-9965.EPI-05-0931","article-title":"Prevalence of chronic atrophic gastritis in different parts of the world","volume":"15","author":"Weck","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107142126_b5-br-0-0-985","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2036.16.s2.13.x","article-title":"Ten-year prospective follow-up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings","volume":"16","author":"Sakaki","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180107142126_b6-br-0-0-985","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00004836-200103000-00003","article-title":"Update on the pathologic approach to the diagnosis of gastritis, gastric atrophy, and Helicobacter pylori and its sequelae","volume":"32","author":"Sipponen","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"key20180107142126_b7-br-0-0-985","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15430\/JCP.2015.20.1.25","article-title":"Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer","volume":"20","author":"Park","year":"2015","journal-title":"J Cancer Prev"},{"key":"key20180107142126_b8-br-0-0-985","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ijc.2910530114","article-title":"Fundal atrophic gastritis as a risk factor for gastric cancer","volume":"53","author":"Tatsuta","year":"1993","journal-title":"Int J Cancer"},{"key":"key20180107142126_b9-br-0-0-985","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/gut.50.3.378","article-title":"The long term results of endoscopic surveillance of premalignant gastric lesions","volume":"50","author":"Whiting","year":"2002","journal-title":"Gut"},{"key":"key20180107142126_b10-br-0-0-985","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.gastro.2008.01.071","article-title":"Gastric cancer risk in patients with premalignant gastric lesions: A nationwide cohort study in the Netherlands","volume":"134","author":"de Vries","year":"2008","journal-title":"Gastroenterology"},{"key":"key20180107142126_b11-br-0-0-985","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/gut.2006.114504","article-title":"Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status","volume":"56","author":"Hansen","year":"2007","journal-title":"Gut"},{"key":"key20180107142126_b12-br-0-0-985","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3109\/00365529409094899","article-title":"Evaluation of pepsinogen A and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions","volume":"29","author":"Hallissey","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"key20180107142126_b13-br-0-0-985","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/gas.37.7.785.791","article-title":"Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: An observational case-control study","volume":"37","author":"Sipponen","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"key20180107142126_b14-br-0-0-985","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1593\/neo.03505","article-title":"Validity of serum pepsinogen I\/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma","volume":"6","author":"Dinis-Ribeiro","year":"2004","journal-title":"Neoplasia"},{"key":"key20180107142126_b15-br-0-0-985","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1080\/00365520802273025","article-title":"Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study","volume":"43","author":"Storskrubb","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"key20180107142126_b16-br-0-0-985","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MEG.0b013e32834d0a0a","article-title":"Serum pepsinogen test for early detection of gastric cancer in a European country","volume":"24","author":"Lomba-Viana","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20180107142126_b17-br-0-0-985","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-230X-14-3","article-title":"The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China","volume":"14","author":"Zhang","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"key20180107142126_b18-br-0-0-985","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/MEG.0000000000000132","article-title":"Helicobacter pylori Study Group of Asociaci\u00f3n Espa\u00f1ola de Gastroenterolog\u00eda (AEG): Accuracy of GastroPanel for the diagnosis of atrophic gastritis","volume":"26","author":"McNicholl","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20180107142126_b19-br-0-0-985","first-page":"261","article-title":"Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis","volume":"7","author":"Inoue","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107142126_b20-br-0-0-985","first-page":"107","article-title":"Screening markers for chronic atrophic gastritis in Chiapas, Mexico","volume":"10","author":"Ley","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107142126_b21-br-0-0-985","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00042737-200308000-00009","article-title":"Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: A multicentre study","volume":"15","author":"V\u00e4\u00e4n\u00e4nen","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20180107142126_b22-br-0-0-985","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10238-006-0098-3","article-title":"Association of serum pepsinogen with atrophic body gastritis in Costa Rica","volume":"6","author":"Sierra","year":"2006","journal-title":"Clin Exp Med"},{"key":"key20180107142126_b23-br-0-0-985","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/aje\/kwj088","article-title":"The serum pepsinogen test as a predictor of gastric cancer: The Hisayama study","volume":"163","author":"Oishi","year":"2006","journal-title":"Am J Epidemiol"},{"key":"key20180107142126_b24-br-0-0-985","first-page":"208","article-title":"Are the serum biomarkers pepsinogen I and II good predictors for the detection of subjects with atrophic gastritis in areas that have different gastric cancer incidence?","volume":"16","author":"Mohamadkhani","year":"2013","journal-title":"Arch Iran Med"},{"key":"key20180107142126_b25-br-0-0-985","first-page":"1317","article-title":"Precancerous gastric lesions in a population at high risk of stomach cancer","volume":"53","author":"You","year":"1993","journal-title":"Cancer Res"},{"key":"key20180107142126_b26-br-0-0-985","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.bjc.6600877","article-title":"Eurohepygast Study Group: Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics","volume":"88","author":"Broutet","year":"2003","journal-title":"Br J Cancer"},{"key":"key20180107142126_b27-br-0-0-985","doi-asserted-by":"crossref","first-page":"47","DOI":"10.15430\/JCP.2014.19.1.47","article-title":"Correlations among endoscopic, histologic and serologic diagnoses for the assessment of atrophic gastritis","volume":"19","author":"Lee","year":"2014","journal-title":"J Cancer Prev"},{"key":"key20180107142126_b28-br-0-0-985","first-page":"302","article-title":"Risk factors in gastric cancer","volume":"14","author":"Compare","year":"2010","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20180107142126_b29-br-0-0-985","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2217\/fon.10.37","article-title":"Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis","volume":"6","author":"Ding","year":"2010","journal-title":"Future Oncol"},{"key":"key20180107142126_b30-br-0-0-985","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MEG.0b013e328346105a","article-title":"Clinical parameters including serum pepsinogen level and management strategy in patients with premalignant gastric dysplasia","volume":"23","author":"Chang","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20180107142126_b31-br-0-0-985","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/MCG.0b013e3181a159c4","article-title":"Stomach cancer risk in gastric cancer relatives: Interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer","volume":"44","author":"Shin","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"key20180107142126_b32-br-0-0-985","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/SMJ.0b013e3180485d24","article-title":"ABO blood group and gastric cancer: Rekindling an old fire?","volume":"100","author":"El Hajj","year":"2007","journal-title":"South Med J"},{"key":"key20180107142126_b33-br-0-0-985","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00008469-200202000-00005","article-title":"Canadian Cancer Registries Epidemiology Research Group: Active and passive smoking and the risk of stomach cancer, by subsite, in Canada","volume":"11","author":"Mao","year":"2002","journal-title":"Eur J Cancer Prev"},{"key":"key20180107142126_b34-br-0-0-985","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0028-1098086","article-title":"An endoscopic recognization of the atrophic border and its significance in chronic gastritis","volume":"1","author":"Kimura","year":"1969","journal-title":"Endoscopy"},{"key":"key20180107142126_b35-br-0-0-985","doi-asserted-by":"crossref","first-page":"6527653","DOI":"10.1155\/2016\/6527653","article-title":"Surrounding gastric mucosa findings facilitate diagnosis of gastric neoplasm as gastric adenoma or early gastric cancer","volume":"2016","author":"Miike","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"key20180107142126_b36-br-0-0-985","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"key20180107142126_b37-br-0-0-985","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/gut.44.5.693","article-title":"Accuracy of screening for gastric cancer using serum pepsinogen concentrations","volume":"44","author":"Kitahara","year":"1999","journal-title":"Gut"},{"key":"key20180107142126_b38-br-0-0-985","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10120-006-0397-0","article-title":"Gastric cancer screening using the serum pepsinogen test method","volume":"9","author":"Miki","year":"2006","journal-title":"Gastric Cancer"},{"key":"key20180107142126_b39-br-0-0-985","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1443-1661.2009.00839.x","article-title":"Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population","volume":"21","author":"Miki","year":"2009","journal-title":"Dig Endosc"},{"key":"key20180107142126_b40-br-0-0-985","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3109\/00365528909089228","article-title":"The ratio of pepsinogen A to pepsinogen C: A sensitive test for atrophic gastritis","volume":"24","author":"Borch","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"key20180107142126_b41-br-0-0-985","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1443-9573.2007.00288.x","article-title":"Factors affecting the serum gastrin 17 level: An evidence-based analysis of 3906 serum samples among Chinese","volume":"8","author":"Zhang","year":"2007","journal-title":"J Dig Dis"},{"key":"key20180107142126_b42-br-0-0-985","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.3748\/wjg.v11.i38.5988","article-title":"Low circulating levels of gastrin-17 in patients with Barrett's esophagus","volume":"11","author":"Sipponen","year":"2005","journal-title":"World J Gastroenterol"},{"key":"key20180107142126_b43-br-0-0-985","first-page":"72","article-title":"A survey and evaluation of population-based screening for gastric cancer","volume":"10","author":"Yuan","year":"2013","journal-title":"Cancer Biol Med"},{"key":"key20180107142126_b44-br-0-0-985","doi-asserted-by":"crossref","first-page":"e3599","DOI":"10.1097\/MD.0000000000003599","article-title":"The diagnostic value of gastrin-17 detection in atrophic gastritis: A meta-analysis","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)"}],"container-title":["Biomedical Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T09:35:33Z","timestamp":1515317733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/br.2017.985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,20]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,9,20]]},"published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.3892\/br.2017.985"],"URL":"https:\/\/doi.org\/10.3892\/br.2017.985","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,20]]}}}